Jiangsu, China

Yongkun Yang


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yongkun Yang: Innovator in Chimeric Antigen Receptor Technology

Introduction

Yongkun Yang is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptors (CARs). His work focuses on innovative solutions for treating diseases linked to specific proteins.

Latest Patents

Yongkun Yang holds two notable patents. The first patent is for a chimeric antigen receptor (CAR) that specifically binds to a BCMA protein. This invention includes a BCMA binding structural domain, a transmembrane domain, a costimulatory domain, and an intracellular signaling domain. The second patent is similar, providing a CAR with the same structural components and uses in treating diseases associated with BCMA expression. These patents highlight his commitment to advancing therapeutic options in the medical field.

Career Highlights

Throughout his career, Yongkun Yang has worked with leading companies in the biotechnology sector. He has been associated with Nanjing Iaso Biotherapeutics Co., Ltd. and Innovent Biologics (Suzhou) Co., Ltd. His experience in these organizations has allowed him to contribute to groundbreaking research and development in biotherapeutics.

Collaborations

Yongkun Yang has collaborated with notable professionals in his field, including Jianfeng Zhou and Junjian Liu. These partnerships have fostered innovation and have been instrumental in the advancement of CAR technology.

Conclusion

Yongkun Yang is a key figure in the development of chimeric antigen receptor technology, with a focus on BCMA-related therapies. His patents and career achievements reflect his dedication to improving medical treatments through innovative inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…